Evergreen’s eighth in Australia as it continues momentum in that region. “This year has been our biggest growth year ever,” Craig Fulton, advisor for brand, M&A and community at San ...

Fee-earning AUM rose to $71 billion, a 13% increase, driven by growth in specialized fund platforms, including an increase in Evergreen products. The firm announced new fundraising milestones ...

The European market for evergreen private markets funds, excluding ELTIFs, continues its steep upward trajectory, with assets ...

Through the transaction, Lantheus has acquired OCTEVY™, a registrational-stage PET diagnostic imaging agent targeting neuroendocrine tumors ... with the addition of Evergreen’s radioligand ...

Through the transaction, Lantheus has acquired OCTEVY™, a registrational-stage PET diagnostic imaging agent targeting neuroendocrine tumors, which complements ... capabilities with the addition of ...